159 related articles for article (PubMed ID: 24868853)
1. Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase.
Karlsson D; Fallarero A; Shinde P; Anju CP; Busygin I; Leino R; Mohan CG; Vuorela P
Nat Prod Commun; 2014 Apr; 9(4):455-8. PubMed ID: 24868853
[TBL] [Abstract][Full Text] [Related]
2. Cation-π and π-π stacking interactions allow selective inhibition of butyrylcholinesterase by modified quinine and cinchonidine alkaloids.
Nawaz SA; Ayaz M; Brandt W; Wessjohann LA; Westermann B
Biochem Biophys Res Commun; 2011 Jan; 404(4):935-40. PubMed ID: 21185266
[TBL] [Abstract][Full Text] [Related]
3. Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis.
Liew SY; Khaw KY; Murugaiyah V; Looi CY; Wong YL; Mustafa MR; Litaudon M; Awang K
Phytomedicine; 2015 Jan; 22(1):45-8. PubMed ID: 25636869
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.
Bosak A; Ramić A; Šmidlehner T; Hrenar T; Primožič I; Kovarik Z
PLoS One; 2018; 13(10):e0205193. PubMed ID: 30289893
[TBL] [Abstract][Full Text] [Related]
5. Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking.
Lima JA; R Costa TW; da Fonseca ACC; do Amaral RF; Nascimento MDDSB; Santos-Filho OA; de Miranda ALP; Ferreira Neto DC; Lima FRS; Hamerski L; Tinoco LW
Bioorg Chem; 2020 Nov; 104():104215. PubMed ID: 32920358
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of quinine: the effects of vinyl and methoxy groups on molecular assemblies of Cinchona alkaloids cannot be ignored.
Hisaki I; Hiraishi E; Sasaki T; Orita H; Tsuzuki S; Tohnai N; Miyata M
Chem Asian J; 2012 Nov; 7(11):2607-14. PubMed ID: 22915374
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.
Khalid A; Zaheer-ul-Haq ; Anjum S; Khan MR; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2004 May; 12(9):1995-2003. PubMed ID: 15080903
[TBL] [Abstract][Full Text] [Related]
8. New cholinesterase inhibitors from Garcinia atroviridis.
Tan WN; Khairuddean M; Wong KC; Khaw KY; Vikneswaran M
Fitoterapia; 2014 Sep; 97():261-7. PubMed ID: 24924287
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Cinchona alkaloids into 1-N-oxide derivatives by endophytic Xylaria sp isolated from Cinchona pubescens.
Shibuya H; Kitamura C; Maehara S; Nagahata M; Winarno H; Simanjuntak P; Kim HS; Wataya Y; Ohashi K
Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):71-4. PubMed ID: 12520132
[TBL] [Abstract][Full Text] [Related]
10. Computational and experimental studies on the interaction between butyrylcholinesterase and fluoxetine: implications in health and disease.
Dalmizrak O; Teralı K; Yetkin O; Ogus IH; Ozer N
Xenobiotica; 2019 Jul; 49(7):803-810. PubMed ID: 30052110
[TBL] [Abstract][Full Text] [Related]
11. Isocorilagin, a cholinesterase inhibitor from Phyllanthus niruri.
Koay YH; Basiri A; Murugaiyah V; Chan KL
Nat Prod Commun; 2014 Apr; 9(4):515-7. PubMed ID: 24868872
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae).
Wan Othman WNN; Liew SY; Khaw KY; Murugaiyah V; Litaudon M; Awang K
Bioorg Med Chem; 2016 Sep; 24(18):4464-4469. PubMed ID: 27492195
[TBL] [Abstract][Full Text] [Related]
13. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
15. Bioactive cinchona alkaloids from Remijia peruviana.
Ruiz-Mesia L; Ruiz-Mesía W; Reina M; Martínez-Diaz R; de Inés C; Guadaño A; González-Coloma A
J Agric Food Chem; 2005 Mar; 53(6):1921-6. PubMed ID: 15769114
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode.
Sawatzky E; Wehle S; Kling B; Wendrich J; Bringmann G; Sotriffer CA; Heilmann J; Decker M
J Med Chem; 2016 Mar; 59(5):2067-82. PubMed ID: 26886849
[TBL] [Abstract][Full Text] [Related]
17. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
[TBL] [Abstract][Full Text] [Related]
18. Effects of cinchonine, a Cinchona bark alkaloid, on spontaneous and induced rat ileum contractions.
Rankovic G; Stankovic V; Zivkovic M; Rankovic B; Laketic D; Potic M; Saranovic M; Rankovic GN
Bratisl Lek Listy; 2019; 120(8):576-580. PubMed ID: 31379180
[TBL] [Abstract][Full Text] [Related]
19. Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives.
Basiri A; Murugaiyah V; Osman H; Kumar RS; Kia Y; Ali MA
Bioorg Med Chem; 2013 Jun; 21(11):3022-31. PubMed ID: 23602518
[TBL] [Abstract][Full Text] [Related]
20. Extraction of alkaloids for NMR-based profiling: exploratory analysis of an archaic Cinchona bark collection.
Yilmaz A; Nyberg NT; Jaroszewski JW
Planta Med; 2012 Nov; 78(17):1885-90. PubMed ID: 23059630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
